Allt inom

Nanexa receives Notice of Allowance for its US patent application

Uppsala 15thNovember 2018

 

Nanexa receives Notice of Allowance for its US patent application

 

The US patent office has issued a “Notice of Allowance” in Nanexa´s US patent application regarding the Company’s drug delivery platform PharmaShell®. 

Read more

Positive results in the feasibility study lead to broader cooperation

Pressrelease

Uppsala 10th October 2018

Positive results in the feasibility study lead to broader cooperation

 

AstraZeneca has conducted a feasibility study for investigating specific properties of Nanexa’s drug delivery platform PharmaShell®.

Read more